Logo image of IMRA

BITWISE MARA INCOME STRAT (IMRA) Stock Price, Forecast & Analysis

USA - NYSEARCA:IMRA - US0917487078 - ETF

30.4112 USD
+1.13 (+3.87%)
Last: 11/5/2025, 8:04:00 PM

IMRA Key Statistics, Chart & Performance

Key Statistics
Market Cap797.80M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares26.23M
Float16.64M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-13 2023-03-13
IPO2020-03-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


IMRA short term performance overview.The bars show the price performance of IMRA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40

IMRA long term performance overview.The bars show the price performance of IMRA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of IMRA is 30.4112 USD. In the past month the price decreased by -20.58%.

BITWISE MARA INCOME STRAT / IMRA Daily stock chart

IMRA Latest News, Press Relases and Analysis

7 months ago - By: Benzinga - Mentions: COIN MSTR MARA IMST ...
News Image
3 years ago - By: Imara, Inc.
News Image
3 years ago - By: Kahn Swick & Foti, LLC
News Image
3 years ago - By: Benzinga - Mentions: EPIX TPL MGNX MEC ...
News Image

IMRA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 42.1 876.24B
JNJ JOHNSON & JOHNSON 17.92 447.95B
AZN ASTRAZENECA PLC-SPONS ADR 18.28 251.61B
NVS NOVARTIS AG-SPONSORED ADR 14.02 242.95B
NVO NOVO-NORDISK A/S-SPONS ADR 12.62 215.33B
MRK MERCK & CO. INC. 9.58 210.79B
PFE PFIZER INC 7.69 139.92B
SNY SANOFI-ADR 11.21 119.42B
GSK GSK PLC-SPON ADR 7.73 93.91B
BMY BRISTOL-MYERS SQUIBB CO 7.08 94.59B
ZTS ZOETIS INC 19 53.40B
TAK TAKEDA PHARMACEUTIC-SP ADR 194.14 42.92B

Related stock screener links

BITWISE MARA INCOME STRAT / IMRA FAQ

What does IMRA do?

Imara, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Brookline, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2020-03-12. The firm is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687 is in Phase IIb clinical development for the treatment of sickle cell disease (SCD) and beta- thalassemia. The company is also focused on initiating a Phase II clinical trial of IMR-687 in heart failure with preserved ejection fraction (HFpEF). The firm is also focused on development of IMR-261, an oral, clinic-ready activator of nuclear factor erythroid 2-related factor 2 (Nrf2).


What is the stock price of BITWISE MARA INCOME STRAT today?

The current stock price of IMRA is 30.4112 USD. The price increased by 3.87% in the last trading session.


How is the ChartMill rating for BITWISE MARA INCOME STRAT?

IMRA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


IMRA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating